A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening

Drug development for specific antiviral agents against coronavirus disease 2019 (COVID-19) is still an unmet medical need as the pandemic continues to spread globally. Although huge efforts for drug repurposing and compound screens have put forth, only few compounds remain in late stage clinical tri...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:bioRxiv
Autori principali: Gorshkov, Kirill, Vasquez, Desarey Morales, Chiem, Kevin, Ye, Chengjin, Tran, Bruce Nguyen, de la Torre, Juan Carlos, Moran, Thomas, Chen, Catherine Z., Martinez-Sobrido, Luis, Zheng, Wei
Natura: Artigo
Lingua:Inglês
Pubblicazione: Cold Spring Harbor Laboratory 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282096/
https://ncbi.nlm.nih.gov/pubmed/34268508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.07.03.450938
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi